Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


People In The News: EFPIA Seeks New Leader, Medicines Australia Finds One

Executive Summary

EFPIA's Richard Bergström is moving on; Medicines Australia brings in UK-based lobbyist Milton Catelin as its CEO; Friends of Cancer Research promotes Jeff Allen to CEO, plus more biopharma personnel changes.

You may also be interested in...

O’Neill Optimistic Global AMR Review Won’t Lose Steam

Jim O'Neill says he spends sleepless nights worrying whether his Review of Antimicrobial Resistance (AMR) will run out of steam once completed in two months' time - but he's encouraged by growing evidence world leaders and the pharma industry are seriously embracing the theme and will soon make lasting commitments to effectively combat antibiotic resistance, including in Asia.

Medicines Australia CEO Resigns After "Challenging" Year

Tim James has resigned as CEO of the pharmaceutical industry body Medicines Australia, effective from January 20161. The search for a successor will begin next year.

QUOTED. 29 September 2020. Phil Brown.

ABHI’s Phil Brown believes the future of UK device regulation will be innovation-friendly and patient-responsive system – but doesn’t expect easy alignment with the EU. See what he had to say.


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts